Clinical Study Results
Where can I learn more about the study?
You can find more information about this study on the websites listed below. If a full
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03371459” into the
search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D6930C00002” into the search box and click “Find a Study”.
Full study title: A randomized, cumulative dose, open-label, 2-period crossover,
multi-center study to assess the safety, efficacy, PK, and extrapulmonary
pharmacodynamics (PD) of cumulative doses of albuterol sulfate pressurized inhalation
suspension (hereafter referred to as AS MDI) compared to cumulative doses of
Proventil® Hydrofluoroalkane (HFA; Hereafter Referred to as Proventil) as an active
control in subjects with mild to moderate asthma (ASPEN)
National Clinical Trial number: NCT03371459
AstraZeneca Protocol number: D6930C00002 (PT007002)
Pearl Therapeutics, Inc, a member of the AstraZeneca Group, sponsored this study
and has its headquarters in Morristown, USA.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for participants.
The Center for Information & Study on Clinical Research Participation (CISCRP)
is a non-profit organization focused on educating and informing the public about
clinical research participation. CISCRP is not involved in recruiting patients for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
8
Version 2.4 2019_02_22